Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Drought is over, turn around day

<< Previous

Bullboard Posts

Next >>

Comment by westcoast1000on Apr 21, 2021 12:24pm

252 Views

Post# 33037511

RE:RE:RE:RE:RE:RE:RE:RE:RE:Drought is over, turn around day

Norman,

You were a wise person to buy at .74 (US?) in 2019.

Many of us had large holdings for five years or more at that point.

For new ONCY holders,

IN my opinion, Canadafan provides honest straight assessments of where the company sits.

It is completely true that things have never looked stronger. And yes, there can still be a big sell-off.
People generally feel they can flip this stock and get back in again easily. There will be a time when that changes.

<< Previous

Bullboard Posts

Next >>

The Market Online’s Weekly Gold Report – Nov. 6, 2024